
About Buchang Pharma
Buchang Pharma is a publicly listed company based in Heze (China) founded in 2001. Chinese medicines are researched, developed, manufactured, and supplied. Its website buchang.com draws about 31 thousand monthly visits. Buchang Pharma offers products and services including Cardiovascular Drugs and Diabetes Medications. Its focus areas include Alternative Medicine Products. Its legal entity is Shandong Buchang Pharmaceutical Co., Ltd.
Company details
Buchang Pharma, based in Heze, focuses on providing healthcare solutions, and alternative medicine products. Researcher, developer, manufacturer, and supplier of chinese medicines. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Heze, China
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website buchang.com
- Legal Name Shandong Buchang Pharmaceuticals Co., Ltd. Class A
- Annual Revenue$1.68 B (USD)7.75as on Dec 31, 2025
- Net Profit$51.53 M (USD)as on Dec 31, 2025
- EBITDA$241.39 M (USD)30.43as on Dec 31, 2025
- InvestorsAIF Capital
& 1 more
Products & Services of Buchang Pharma
Buchang Pharma offers a comprehensive portfolio of products and services, including Cardiovascular Drugs and Diabetes Medications.
Drugs are developed for treating heart and cerebral vessel conditions using traditional Chinese medicine approaches.
Medications are provided for diabetes management as part of the company's focus on major disease areas.
Funding Insights of Buchang Pharma
- Total Rounds 3
- Investors Count 2
All 3 funding rounds of Buchang Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2011 | Series A | β | β | ||
| Jun 2010 | Series A | β | Shanghai Changjiang Guohong Investment Management | β | |
| Jan 2008 | Series A | β | Shanghai Changjiang Guohong Investment Management | β |
2 investors in total: 2 institutional.
Investors in Buchang Pharma
Buchang Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include AIF Capital and Grand Yangtze.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment funding and expertise for emerging businesses in Asia. | 1994 | aifcapital.com | ||
Private equity investments are managed by the company. | 2012 | grandyangtze.com | Shanghai, China |
Investor details for Buchang Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of Buchang Pharma
Buchang Pharma is a publicly listed company on the SSE with ticker symbol 603858 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Nov 2016
- Listed onSSE: 603858
- Listed entityShandong Buchang Pharmaceuticals Co., Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE100002FV6
- Share price14.60 CNY (-0.07% on the day) · 2026-10-14
- Market capitalisation14,888,035,512.00 CNY
- Price to earnings64.7
- EPS (diluted, trailing year)0.23 CNY
- Dividend yield3.85%
- Volume (last session)2,772,338
Financials of Buchang Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 11.76B CNY | 360.8M CNY | 1.69B CNY |
| 2024 | 10.92B CNY | -553.8M CNY | 1.30B CNY |
| 2023 | 13.11B CNY | 319.0M CNY | 1.65B CNY |
| 2022 | 14.78B CNY | -1.53B CNY | 2.30B CNY |
| 2021 | 15.59B CNY | 1.29B CNY | 2.24B CNY |
Detailed financial statements for Buchang Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Buchang Pharma
4 dated milestones of Buchang Pharma across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Buchang Pharma is founded.
- Funding First funding round.
- Funding Latest funding round, Series A,.
- IPO Lists on the stock exchange (IPO).
Web traffic of Buchang Pharma
The website of Buchang Pharma (buchang.com) receives about 30.8K visits a month and ranks #572,102 among all websites worldwide, #599 in Biotechnology and Pharmaceuticals.
- Monthly visits30.8K
- Unique visitors3.4K
per month
- Global rank#572,102
among all websites
- Category rank#599
Health · Biotechnology and Pharmaceuticals
- Bounce rate16%
- Pages per visit14.3
- Average visit9 min 00 sec
- DevicesDesktop 97% Β· Mobile 3%
Websites whose visitors overlap most with Buchang Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
zgylbx.com | zgylbx.com | 100% | #4,610,925 | β | |
baxter.com.cn | baxter.com.cn | 100% | #14,321,318 | β | |
sqys.com | sqys.com | 66% | #6,479,190 | β | |
zryhyy.com.cn | zryhyy.com.cn | 66% | β | ||
healthcare.philips.com | healthcare.philips.com | 66% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 20 similar websites and full traffic analytics for Buchang Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Buchang Pharma
Complete news archive for Buchang Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Buchang Pharma
Buchang Pharma was founded in 2001 and raised its 1st funding round 7 years after it was founded.
Buchang Pharma is headquartered in Heze, China. It is registered at Heze, Shandong, China.
Annual revenue of Buchang Pharma is $1.68B as on Dec 31, 2025.
Buchang Pharma, based in Heze, focuses on providing healthcare solutions, and alternative medicine products. Researcher, developer, manufacturer, and supplier of chinese medicines. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Buchang Pharma offers Cardiovascular Drugs and Diabetes Medications.
Yes, Buchang Pharma is publicly traded on SSE under the ticker symbol 603858.
Buchang Pharma has 2 investors. Key investors include AIF Capital, and Grand Yangtze.
Buchang Pharma operates through Shandong Buchang Pharmaceutical Co., Ltd.
